The T cell receptor beta locus (TRB) encodes the beta chain component of the alpha-beta T cell receptor complex, a critical signaling receptor essential for adaptive immune responses 1. TRB functions as part of the alphabeta TCR, which mediates T cell activation through binding to peptide-MHC complexes and initiates downstream signaling cascades in the T cell receptor signaling pathway 1. At the molecular level, TRB is positioned on the plasma membrane where it operates as a signaling receptor capable of detecting tumor cells and orchestrating T cell-mediated cytotoxicity against tumor targets [GO annotations]. TRB expression can be accurately identified in single-cell RNA sequencing datasets through modular TCR gene expression scoring, demonstrating stable performance across different tissues and gamma-delta T cell subtypes 1. Clinically, TRB variants and expression levels have implications for anti-tumor immune responses, particularly in the context of immunotherapy efficacy. The TCR beta chain's ability to activate T cells and direct them toward malignant cells positions it as a fundamental component of cancer immunosurveillance. Understanding TRB regulation and function is relevant for developing improved immunotherapeutic strategies, especially given the growing importance of T cell-based cancer treatments and checkpoint immunotherapy approaches 1.